Skip to main content

Find Clinical Trials

Home
Conditions
Patients Who Undergo Pancreaticoduodenectomy

Clinical trial condition

Patients Who Undergo Pancreaticoduodenectomy

Explore clinical trials studying Patients Who Undergo Pancreaticoduodenectomy. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

Patients Who Undergo Pancreaticoduodenectomy trial results

Recruiting

Safety and Efficacy of Anricfen for Postoperative Analgesia and Rehabilitation Promotion After Pancreaticoduodenectomy.Intervention Measures: For Normal Adults, Administer Ariceptin Injection Intravenously Post-operation at a Dose of 1 μg/Kgevery 8 Hours for Three Consecutive Days After Surgery.

NCT07514637

Conditions: Agnosia, Nervous System Diseases, Neurobehavioral Manifestations, +5 more
Locations: NanJing drum tower hospital Nanjing, China

View Trial Details